Bazireh Homa, Shariati Parvin, Azimzadeh Jamalkandi Sadegh, Ahmadi Ali, Boroumand Mohammad Ali
Department of Bioprocess Engineering, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Front Microbiol. 2020 Dec 4;11:597946. doi: 10.3389/fmicb.2020.597946. eCollection 2020.
Probiotics are non-pathogenic microorganisms that can interact with the gastrointestinal microbiota. They have numerous beneficial health effects that include enhancement of the host immune response, antiallergic, antimicrobial, anti-cancer, and anti-inflammatory properties. Probiotics are capable of restoring the impaired microbiome of a dysbiotic gut. They can be isolated from different environments. However, it is frequently suggested that probiotics for human use should come from human sources. The objective of this study was to isolate and characterize novel probiotic strains from the saliva and feces of healthy human individuals. To meet the criteria for probiotic attributes, the isolates were subjected to numerous standard morphological and biochemical tests. These tests included Gram staining, catalase tests, antibiotic susceptibility testing, hemolytic and antagonistic evaluation, tolerance tests involving temperature, NaCl levels, pH and bile salts, adherence ability assays, and genotypic characterization involving 16S rRNA gene sequencing. From 26 saliva and 11 stool samples, 185 microbial strains were isolated. Based on morphological and biochemical characteristics, 14 potential probiotic candidates were selected and identified genotypically. The new strains belonged to , and . The selected strains were non-hemolytic, showed high tolerance to low pH and bile salts, and strong adherence abilities. Furthermore, the strains displayed a wide range of antimicrobial activities, particularly against antibiotic-resistant pathogens such as methicillin resistant (MRSA). Moreover, five of the selected isolates demonstrated antiproliferative features against human colon cancer cell line (Caco-2). The results of this investigation confirm the diversity of microbial populations in the human gut and saliva, and since these strains are of human origin, they will highly likely display maximal activities in food and drugs set for human use. Hence, the new strains of this study require additional experiments to assess their health-promoting effects.
益生菌是可与胃肠道微生物群相互作用的非致病微生物。它们具有众多有益健康的作用,包括增强宿主免疫反应、抗过敏、抗菌、抗癌和抗炎特性。益生菌能够恢复失调肠道受损的微生物群。它们可从不同环境中分离得到。然而,人们经常建议用于人类的益生菌应来源于人类。本研究的目的是从健康人类个体的唾液和粪便中分离并鉴定新型益生菌菌株。为符合益生菌特性标准,对分离菌株进行了多项标准形态学和生化测试。这些测试包括革兰氏染色、过氧化氢酶测试、抗生素敏感性测试、溶血和拮抗评估、涉及温度、氯化钠水平、pH值和胆盐的耐受性测试、黏附能力测定以及涉及16S rRNA基因测序的基因型鉴定。从26份唾液和11份粪便样本中分离出185株微生物菌株。根据形态学和生化特征,选择了14株潜在益生菌候选菌株并进行基因型鉴定。新菌株属于 、 和 。所选菌株无溶血现象,对低pH值和胆盐具有高耐受性,且黏附能力强。此外,这些菌株表现出广泛的抗菌活性,尤其是对耐甲氧西林金黄色葡萄球菌(MRSA)等耐药病原体。此外,所选的5株分离株对人结肠癌细胞系(Caco-2)表现出抗增殖特性。本研究结果证实了人类肠道和唾液中微生物种群的多样性,并且由于这些菌株来源于人类,它们极有可能在供人类使用的食品和药物中发挥最大活性。因此,本研究中的新菌株需要进行额外实验以评估其促进健康的作用。